Clinical Trials Browser

Phase 1/2 × Lung Neoplasms × Bexarotene × Clear all

NCT00238628 2010-07-20

A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer

Phase 1/2 Completed

Lung Neoplasms